Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASP1517 Phase 2 Clinical Trial -A Multi-center, Randomized, Parallel Groups, Placebo-controlled, Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-

NCT01964196 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01964196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01964196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASP1517 Phase 2 Clinical Trial -A Multi-center, Randomized, Parallel Groups, Placebo-controlled, Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
September 17, 2013
Completion date
December 1, 2015
Enrollment
107 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

anemia in chronic kidney disease patients not on dialysis